Zobrazeno 1 - 10
of 42
pro vyhledávání: '"L, Rebella"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Spigno F, Andrea Bruzzone, A Grimaldi, A Salami, Riccardo Ghio, F Scasso, M Figliomeni, F Grillo-Ruggieri, G Moratti, M Dellepiane, L. Rebella, M Mencoboni
Publikováno v:
European Journal of Cancer Care. 20:503-507
Concurrent chemoradiotherapy has become the standard of care for patients with inoperable squamous cell head and neck carcinoma. More recently, induction chemotherapy has been adopted as an approach in the management of these patients. We report the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fee822a03a1a37b1f08bcc9eb6e8272c
https://doi.org/10.1111/j.1365-2354.2010.01185.x
https://doi.org/10.1111/j.1365-2354.2010.01185.x
Autor:
M, Mencoboni, F, Grillo-Ruggieri, A, Salami, F, Scasso, L, Rebella, A, Grimaldi, M, Dellepiane, G, Moratti, A, Bruzzone, F, Spigno, R, Ghio, M, Figliomeni
Publikováno v:
European journal of cancer care. 20(4)
Concurrent chemoradiotherapy has become the standard of care for patients with inoperable squamous cell head and neck carcinoma. More recently, induction chemotherapy has been adopted as an approach in the management of these patients. We report the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0a5673c5049b8bc1085c59eb81f56411
https://pubmed.ncbi.nlm.nih.gov/20477856
https://pubmed.ncbi.nlm.nih.gov/20477856
Autor:
M, Mencoboni, M, Bergaglio, M, Serra, G P, Ivaldi, S, Tredici, O, Racchi, L, Rebella, V, Galbusera, M, Grosso, B, Faravelli
Publikováno v:
Anticancer research. 27(6C)
Chemotherapy extends life for patients with advanced non-small cell lung cancer (NSCLC). Second-line treatment of NSCLC includes the use of cytotoxic drugs; however, toxicity is of concern. One molecular target for lung cancer is the epidermal growth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::afc4a259225383a3f7925dcf2829ca0e
https://pubmed.ncbi.nlm.nih.gov/18214055
https://pubmed.ncbi.nlm.nih.gov/18214055
Autor:
A. Muzio, M. Serra, M. Botta, R. Carbone, E. Piccolini, Manlio Mencoboni, V. Galbusera, E. Aitini, B. Castagneto, Spigno F, D. Degiovanni, L. Rebella, R. Buosi, L. Giaretto, Oscar Alabiso
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 19(2)
Background The aim of this study was to evaluate the activity and toxicity of pemetrexed and carboplatin combination as first-line chemotherapy in malignant pleural mesothelioma (MPM). Patients and methods Patients with measurable advanced MPM and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef1c8ea304630687affbf6b5bd79a431
https://pubmed.ncbi.nlm.nih.gov/18156144
https://pubmed.ncbi.nlm.nih.gov/18156144
Autor:
M P, Mencoboni, S, Tredici, M, Varaldo, G, Queirolo, F, Durand, L, Rebella, V, Galbusera, I M, Pannacciulli, R, Ghio
Publikováno v:
Neoplasma. 53(4)
Systemic therapies employed in patients with metastatic renal cell carcinoma (MRCC) include chemotherapy to immunomodulatory cytokines (interleukin 2 [IL-2], interferon alpha [INFalpha]), chemoimmunotherapy, adoptive immune therapy and anti-angiogeni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::de491ed3a90590f10f532366e237e373
https://pubmed.ncbi.nlm.nih.gov/16830062
https://pubmed.ncbi.nlm.nih.gov/16830062
Autor:
M, Mencoboni, L, Rebella, S, Tredici, M, Bergaglio, M, Delle Piane, A, Salami, M, Bavazzano, R, Ghio, A, Grimaldi, D, Scarpati
Publikováno v:
I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.]. 4(3)
Usually head and neck cancer is treated with combined therapy, applying surgery, if possible, and then radiotherapy and chemotherapy in a sequential or concomitant way. Sequential approach seems to be preferred, because of the high toxicity rate of c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6a99c9d382b10bf47987933ad542b415
https://pubmed.ncbi.nlm.nih.gov/16437998
https://pubmed.ncbi.nlm.nih.gov/16437998
Autor:
M, Mencoboni, L, Rebella, S, Tredici, R, Ghio, D, Scarpati, M, Bavazzano, B, Jankowska, M, Delle Piane
Publikováno v:
Anticancer research. 25(6C)
For many years surgery was the cornerstone of treatment for head and neck cancers and radiotherapy was the treatment of choice in adjuvant and advanced inoperable settings. Recently, induction sequential chemotherapy followed by radiotherapy has show
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c3bd1e18498a8e8e4cbedbe759364fb2
https://pubmed.ncbi.nlm.nih.gov/16334125
https://pubmed.ncbi.nlm.nih.gov/16334125
Autor:
G, Villa, E, Balleari, M, Carletto, M, Grosso, M, Clavio, A, Piccardo, L, Rebella, L, Tommasi, S, Morbelli, F, Peschiera, M, Gobbi, R, Ghio
Publikováno v:
Journal of experimentalclinical cancer research : CR. 24(3)
The aim of the present study was the evaluation of the diagnostic value of 99mTc-sestamibi (MIBI) in the detection of bone marrow involvement in patients suffering from multiple myeloma (MM) and its possible role in the follow-up. Between 1998 and 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f3fa5847326fddc3ec185879c9f2ff48
https://pubmed.ncbi.nlm.nih.gov/16270521
https://pubmed.ncbi.nlm.nih.gov/16270521
Autor:
M. Bergaglio, M. Paganuzzi, Rosangela Filiberti, M. Mencoboni, M. Gianola, V. Galbusera, R. Puntoni, G. Tunesi, L. Rebella, M. Serra
Publikováno v:
European Journal of Cancer Supplements. 5:364
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::173266fd253bbcbaa93e60850c7f1662
https://doi.org/10.1016/s1359-6349(07)71351-4
https://doi.org/10.1016/s1359-6349(07)71351-4